- Previous Close
165.00 - Open
159.00 - Bid 141.00 x --
- Ask 159.00 x --
- Day's Range
136.00 - 165.00 - 52 Week Range
110.00 - 350.00 - Volume
52,921 - Avg. Volume
122,029 - Market Cap (intraday)
1.347B - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
-- - EPS (TTM)
-0.29 - Earnings Date Apr 7, 2025
- Forward Dividend & Yield 0.12 (7.27%)
- Ex-Dividend Date May 7, 2025
- 1y Target Est
--
AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers HIV and other healthcare management solutions. The company engages in the retail and wholesale of pharmaceutical products under the Activo Health, AfroCentric Technologies, AfA, Allegra, Denis, EssentialMED, Klinikka, Medscheme, Pharmacy Direct, Scriptpharm, Tendahealth, Forrester Pharma, Pharmacy Direct, Curasana Wholesaler, The Cheese has Moved, and other brand names. AfroCentric Investment Corporation Limited operates in South Africa, Botswana, Mauritius, Namibia, and Eswatini. The company was founded in 2008 and is based in Roodepoort, South Africa. AfroCentric Investment Corporation Limited operates as a subsidiary of Sanlam Limited.
www.afrocentric.za.comRecent News: ACT.JO
View MorePerformance Overview: ACT.JO
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is All Share Index (^J203.JO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACT.JO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACT.JO
View MoreValuation Measures
Market Cap
1.35B
Enterprise Value
1.79B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.16
Price/Book (mrq)
0.42
Enterprise Value/Revenue
0.21
Enterprise Value/EBITDA
4.74
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.77%
Return on Assets (ttm)
24.67%
Return on Equity (ttm)
-6.61%
Revenue (ttm)
8.81B
Net Income Avi to Common (ttm)
-244.24M
Diluted EPS (ttm)
-0.29
Balance Sheet and Cash Flow
Total Cash (mrq)
357M
Total Debt/Equity (mrq)
24.12%
Levered Free Cash Flow (ttm)
1.53B